• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Gold Market
Gold News
Gold Stocks
Gold Price
  • Gold Market
  • Gold News
  • Gold Stocks
  • Gold Price

Dalradian Resources Reports Q3 Results

Written by Charlotte McLeod
|
Nov. 16, 2015 03:56PM PST

Dalradian Resources Inc. (TSX:DNA) announced its results for Q3 2015, as well as the first nine months of the year. The company incurred a net loss of $2.1 million, or $0.01 per share, for the quarter; that’s up from a net loss of $1.2 million in the year-ago period.

Dalradian Resources Inc. (TSX:DNA) announced its results for Q3 2015, as well as the first nine months of the year. The company incurred a net loss of $2.1 million, or $0.01 per share, for the quarter; that’s up from a net loss of $1.2 million in the year-ago period.
Other financial highlights are as follows:

  • Corporate reorganization to reduce ongoing corporate costs
  • Subsequent to the end of Q3 2015, closed a bought deal financing for gross proceeds of approximately $40 million
  • Cash and cash equivalents were $24.4 million at September 30, 2015 (excluding approximately $40 million in gross proceeds from the bought deal financing above) compared with $37.0 million at September 30, 2014
  • Spending on asset evaluation, which includes development planning, permitting and other activities associated with the Underground Program, was $7.2 million in the three months ended September 30, 2015 compared with $1.2 million in the comparable period of 2014 due to an increase in on-site activities associated with the Underground Program; similarly for the nine months ended September 30, 2015, asset evaluation spending was $22.1 million compared to $3.0 million in the comparable period of 2014
  • Exploration expenditures were $1.3 million in the three months ended September 30, 2015 compared with $0.3 million in the comparable period of 2014; for the nine months ended September 30, 2015 exploration expenditures were $1.3 million compared to $1.1 million in the comparable period of 2014 

Patrick F.N. Anderson, chairman and CEO of Dalradian, commented:

The confidence the market has shown by giving us further funding during a downturn of the commodity cycle speaks to the quality of our high-grade Curraghinalt gold project, which we are advancing toward permitting. Leading up to submission of our planning application, we will be releasing results from an additional 35,000 metres of infill drilling, the two test stopes, an updated resource and a feasibility study, as well as completing our ESIA. This program of work makes Dalradian one of the most active gold companies globally.

Click here to read the full Dalradian Resources Inc. (TSX:DNA) press release.

bought deal financing gold companies tsx:dna
The Conversation (0)

Go Deeper

AI Powered
small gold nuggets on a scale

5 Top Weekly TSXV Performers: Rackla Shares Climb After New Stakes Claimed

Industrial vehicles moving ore at a mine site. Text reads "5 Top Canadian Mining Stocks This Week."

Top 5 Canadian Mining Stocks This Week: GPM Metals Leads With 37 Percent Gain

Latest News

Outlook Reports world

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
  • Energy
    • Uranium
    • Oil and Gas
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Industrial Metals
  • Agriculture
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Gaming
    • Cleantech
    • Emerging Tech
Life Science
    • Biotech
    • Cannabis
    • Psychedelics
    • Pharmaceuticals

Featured Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES